Literature DB >> 23614252

Persisting leprosy transmission despite increased control measures in an endemic cluster in Brazil: the unfinished agenda.

Carlos H Alencar1, Alberto N Ramos, Jaqueline C Barbosa, Ligia R F S Kerr, Maria L W De Oliveira, Jorg Heukelbach.   

Abstract

OBJECTIVE: To provide an evidence base for improvement of leprosy control in Brazil's high transmission areas.
DESIGN: We obtained data from municipalities in a major disease cluster from databases for notifiable diseases of four states (Maranhão, Parâ, Tocantins, Piauí), including notifications from 2001 to 2009. Indicators for monitoring and evaluation of leprosy according to the World Health Organization were evaluated with emphasis on the rates of new cases presenting grade-2 disabilities and among children < 15 years of age, indicating late diagnosis and active transmission, respectively.
RESULTS: A total of 82,463 leprosy cases were detected in the area (mean annual case detection rate: 95.9/100,000; RR = 4.56 as compared to the rest of Brazil; 95% CI: 4.45-4.66, P < 0.0001). There was a steady decrease of detection rates in the study period, from 100.8 to 75.6/100,000 inhabitants. In children <15 years of age, 9,009 cases of leprosy were detected (28.40/100,000), significantly more than in the rest of Brazil (RR = 5.80; 95% CI: 5.39-6.25, P < 0.0001). New cases with grade-2 disabilities/100,000 population maintained a stable trend at a high level (4.43 cluster vs. 1.28 rest of country; RR = 3.46; 95% CI: 3.11-3.84, P < 0.0001), whereas the proportion of new cases with grade-2 was slightly lower than the country's average (5.51% vs. 6.75%; RR = 0.84; 95% CI: 0.81-0.86, P < 0.0001).
CONCLUSIONS: Despite recently improved leprosy control measures, there is still major active transmission and late diagnosis in the cluster. Further specific actions are needed to improve early case detection and prompt treatment with the aim to reduce disease burden in the population, considering social inequities.

Entities:  

Mesh:

Year:  2012        PMID: 23614252

Source DB:  PubMed          Journal:  Lepr Rev        ISSN: 0305-7518            Impact factor:   0.537


  6 in total

1.  Trends of main indicators of leprosy in Brazilian municipalities with high risk of leprosy transmission, 2001-2012.

Authors:  Lucia R S Freitas; Elisabeth C Duarte; Leila P Garcia
Journal:  BMC Infect Dis       Date:  2016-09-05       Impact factor: 3.090

2.  Micro-spatial distribution of malaria cases and control strategies at ward level in Gwanda district, Matabeleland South, Zimbabwe.

Authors:  Tawanda Manyangadze; Moses J Chimbari; Margaret Macherera; Samson Mukaratirwa
Journal:  Malar J       Date:  2017-11-21       Impact factor: 2.979

3.  Measuring endemicity and burden of leprosy across countries and regions: A systematic review and Delphi survey.

Authors:  Dorcas O Ogunsumi; Vivek Lal; Karl Philipp Puchner; Wim van Brakel; Eva-Maria Schwienhorst-Stich; Christa Kasang; Joseph Chukwu; Saskia Kreibich; Sandra Parisi; Jan Hendrik Richardus; David J Blok
Journal:  PLoS Negl Trop Dis       Date:  2021-09-20

4.  Factors Contributing to the Delay in Diagnosis and Continued Transmission of Leprosy in Brazil--An Explorative, Quantitative, Questionnaire Based Study.

Authors:  Mary Henry; Noêmi GalAn; Katherine Teasdale; Renata Prado; Harpreet Amar; Marina S Rays; Lesley Roberts; Pedro Siqueira; Gilles de Wildt; Marcos Virmond; Pranab K Das
Journal:  PLoS Negl Trop Dis       Date:  2016-03-15

5.  Leprosy and gender in Brazil: trends in an endemic area of the Northeast region, 2001-2014.

Authors:  Eliana Amorim de Souza; Anderson Fuentes Ferreira; Reagan Nzundu Boigny; Carlos Henrique Alencar; Jorg Heukelbach; Francisco Rogerlândio Martins-Melo; Jaqueline Caracas Barbosa; Alberto Novaes Ramos
Journal:  Rev Saude Publica       Date:  2018-02-26       Impact factor: 2.106

6.  Leprosy: clinical and epidemiological study in patients above 60 years in Espírito Santo State - Brazil.

Authors:  Lucia Martins Diniz; Leonardo Bezerra Maciel
Journal:  An Bras Dermatol       Date:  2018 Nov/Dec       Impact factor: 1.896

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.